All stock lists
Unlock the score
Pulse Biosciences, Inc. (NASDAQ:PLSE)
US · Delayed Price · Currency is USD
Healthcare · Medical - Instruments & Supplies
52.84-0.18 (-0.35%)
Market cap
$3.77B
Insider Score
Health Score
Analyst consensus
Listed since
May 18, 2016
Website
Insider Score
/ 100
PLSE Insider Score
PULSE BIOSCIENCES, INC. has a live Insider Score.
Scored on 4 qualifying trades from 1 insider in the last 90 days.
PLSE analyst forecast
PLSE analyst consensus
Moderate Buy2 ratings
Buy 2 Hold 0 Sell 0
Based on each firm’s most recent rating in the last 3 months — one vote per firm, so a desk that reiterates weekly does not count three times.
PLSE 12-month price target
$59.00+12.0% upsideaverage of 2 firms
$60.00High
$58.00Low
Best analysts covering PLSE
No firm covering PLSE has enough calls with a finished 1Y holding period to rank yet.
Measured by us from each firm’s own rating dates and this stock’s split- and dividend-adjusted closes. How we calculate this.
PLSE analyst ratings
| Firm | Price target | Action | ||||
|---|---|---|---|---|---|---|
| Oppenheimer | Outperform | $60.00 | +14.4% | Reiterated | 2026-10-13 | |
| Canaccord Genuity | Buy | $58.00 | +14.9% | Reiterated | 2026-10-06 | |
| — | Canaccord Genuity | Buy | — | — | Reiterated | 2026-08-10 |
| — | Maxim Group | Hold | — | — | Downgraded | 2022-09-21 |
| — | HC Wainwright & Co. | Neutral | — | — | Downgraded | 2022-05-13 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2022-04-01 |
| — | Stephens & Co. | Overweight | — | — | Reiterated | 2022-04-01 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2022-02-10 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2021-11-16 |
| — | Stephens & Co. | Overweight | — | — | Reiterated | 2021-07-27 |
| — | Maxim Group | Buy | — | — | Reiterated | 2021-03-11 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2021-01-26 |
| — | H.C. Wainwright | Buy | — | — | Upgraded | 2020-05-12 |
| — | HC Wainwright & Co. | Buy | — | — | Upgraded | 2020-05-12 |
| — | HC Wainwright & Co. | Neutral | — | — | Downgraded | 2020-02-14 |
| — | H.C. Wainwright | Neutral | — | — | Downgraded | 2020-02-14 |
| — | H.C. Wainwright | Buy | — | — | Reiterated | 2019-02-25 |
PLSE earnings vs. estimates
| Quarter | EPS est. | EPS actual | Revenue est. | Revenue actual |
|---|---|---|---|---|
| 2026-02-19 | -0.27 | -0.26 | $150K | $264K |
| 2026-05-04 | -0.32 | -0.27 | $250K | $400K |
| 2026-08-06 | -0.31 | -0.36 | $500K | $434K |
| 2026-11-05 | -0.31 | 0.00 | $521K | $0 |
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.